$74,725,667
TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Funds genomic surveillance of travelers to detect and monitor disease variants in real-time.
Enables early detection of emerging pathogens and variants at borders, critical for pandemic preparedness and public health response.
Drives demand for high-throughput sequencing equipment, bioinformatics platforms, and genomic analysis infrastructure from suppliers like Illumina and others.
U.S. investment in genomic surveillance capability counters China's dominance in sequencing technology and positions U.S. biotech leadership in pathogen detection.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002213.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75D30125C20439_7523_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.